In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkad322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Mei-Chen Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan. Hauptthemen laut MEDLINE: Flavobacteriaceae Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health Research Institutes, Ministry of Science and Technology, MOST.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan.
- Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan.
- Department of Pathology, Division of Clinical Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
ORCID-Profile: Shu-Chen Kuo
Förderung
- National Health Research Institutes
- Ministry of Science and Technology
- MOST
Zitieren
APA
Tan, M. C., Huang, Y. C., Chen, P. J., Huang, W. C., Hsu, S. Y., Wang, H. Y., Liou, C. H., Sun, J. R., Lauderdale, T. Y., & Kuo, S. C. (2024). In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad322
Vancouver
Tan MC, Huang YC, Chen PJ, Huang WC, Hsu SY, Wang HY, et al. In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkad322
BibTeX
@article{Tan2024,
author = {Tan, Mei-Chen and Huang, Ying-Chi and Chen, Pei-Jing and Huang, Wei-Cheng and Hsu, Shu-Yuan and Wang, Hui-Ying and Liou, Ci-Hong and Sun, Jun-Ren and Lauderdale, Tsai-Ling Yang and Kuo, Shu-Chen},
title = {In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkad322}
}
EUVIMED